michigan glp-1 gastrointestinal obstruction class action Glucagon-Like Peptide-1 Receptor Agonists and Adverse Events: A Systematic Review and Meta-Analysis glp-1 gastrointestinal obstruction legal team

Ocular complications have also been reported in some cases

Clinical evidence shows GLP-1 agonists produce significantly greater weight loss1522% of body weight in clinical trialscompared to phentermine's typical 510% weight reduction

Heres what they do: Help your body release insulin when your blood sugar is high Reduce another hormone called glucagon that usually increases blood sugar Slow down digestion , so you feel full for longer Send signals to your brain to curb hunger and reduce cravings This multi-action approach is what makes GLP-1 drugs helpful in both type 2 diabetes and weight management If Our Body Already Makes GLP-1, Why Take It From Outside

Our results indicated a no observed adverse effect level (NOAEL) of 2 nmol/kg/day for Ex-4 and a maximal tolerated dose (MTD) of 20 nmol/kg/day